By using a novel, non-radioactive, chelate-forming compound.
(Update): Anti-CKAP4 Monoclonal Antibody Obtained
Cell Surface Antigen CD48 as A Novel Molecular Target for Antibody Therapy in Multiple Myeloma
Investment / Co-development Opportunity for Start-up Company